TY - JOUR
T1 - Detailed Assessment of the "i Need Help" Criteria in Patients with Heart Failure
T2 - Insights from the HELP-HF Registry
AU - Pagnesi, Matteo
AU - Ghiraldin, Daniele
AU - Vizzardi, Enrico
AU - Chiarito, Mauro
AU - Stolfo, Davide
AU - Baldetti, Luca
AU - Adamo, Marianna
AU - Lombardi, Carlo Mario
AU - Inciardi, Riccardo Maria
AU - Tomasoni, Daniela
AU - Loiacono, Ferdinando
AU - Maccallini, Marta
AU - Villaschi, Alessandro
AU - Gasparini, Gaia
AU - Montella, Marco
AU - Contessi, Stefano
AU - Cocianni, Daniele
AU - Perotto, Maria
AU - Barone, Giuseppe
AU - Sartori, Samantha
AU - Davison, Beth A.
AU - Merlo, Marco
AU - Cappelletti, Alberto Maria
AU - Sinagra, Gianfranco
AU - Pini, Daniela
AU - Metra, Marco
N1 - Publisher Copyright:
© 2023 Lippincott Williams and Wilkins. All rights reserved.
PY - 2023/12/1
Y1 - 2023/12/1
N2 - BACKGROUND: The "I Need Help" markers have been proposed to identify patients with advanced heart failure (HF). We evaluated the prognostic impact of these markers on clinical outcomes in a real-world, contemporary, multicenter HF population. METHODS: We included consecutive patients with HF and at least 1 high-risk "I Need Help" marker from 4 centers. The impact of the cumulative number of "I Need Help" criteria and that of each individual "I Need Help" criterion was evaluated. The primary end point was the composite of all-cause mortality or first HF hospitalization. RESULTS: Among 1149 patients enrolled, the majority had 2 (30.9%) or 3 (22.6%) "I Need Help" criteria. A higher cumulative number of "I Need Help" criteria was independently associated with a higher risk of the primary end point (adjusted hazard ratio for each criterion increase, 1.19 [95% CI, 1.11-1.27]; P<0.001), and patients with >5 criteria had the worst prognosis. Need of inotropes, persistently high New York Heart Association classes III and IV or natriuretic peptides, end-organ dysfunction, >1 HF hospitalization in the last year, persisting fluid overload or escalating diuretics, and low blood pressure were the individual criteria independently associated with a higher risk of the primary end point. CONCLUSIONS: In our HF population, a higher number of "I Need Help" criteria was associated with a worse prognosis. The individual criteria with an independent impact on mortality or HF hospitalization were need of inotropes, New York Heart Association class or natriuretic peptides, end-organ dysfunction, multiple HF hospitalizations, persisting edema or escalating diuretics, and low blood pressure.
AB - BACKGROUND: The "I Need Help" markers have been proposed to identify patients with advanced heart failure (HF). We evaluated the prognostic impact of these markers on clinical outcomes in a real-world, contemporary, multicenter HF population. METHODS: We included consecutive patients with HF and at least 1 high-risk "I Need Help" marker from 4 centers. The impact of the cumulative number of "I Need Help" criteria and that of each individual "I Need Help" criterion was evaluated. The primary end point was the composite of all-cause mortality or first HF hospitalization. RESULTS: Among 1149 patients enrolled, the majority had 2 (30.9%) or 3 (22.6%) "I Need Help" criteria. A higher cumulative number of "I Need Help" criteria was independently associated with a higher risk of the primary end point (adjusted hazard ratio for each criterion increase, 1.19 [95% CI, 1.11-1.27]; P<0.001), and patients with >5 criteria had the worst prognosis. Need of inotropes, persistently high New York Heart Association classes III and IV or natriuretic peptides, end-organ dysfunction, >1 HF hospitalization in the last year, persisting fluid overload or escalating diuretics, and low blood pressure were the individual criteria independently associated with a higher risk of the primary end point. CONCLUSIONS: In our HF population, a higher number of "I Need Help" criteria was associated with a worse prognosis. The individual criteria with an independent impact on mortality or HF hospitalization were need of inotropes, New York Heart Association class or natriuretic peptides, end-organ dysfunction, multiple HF hospitalizations, persisting edema or escalating diuretics, and low blood pressure.
KW - heart failure
KW - hospitalization
KW - mortality
KW - patient readmission
KW - prognosis
UR - http://www.scopus.com/inward/record.url?scp=85180418339&partnerID=8YFLogxK
U2 - 10.1161/CIRCHEARTFAILURE.123.011003
DO - 10.1161/CIRCHEARTFAILURE.123.011003
M3 - Article
C2 - 37909222
AN - SCOPUS:85180418339
SN - 1941-3289
VL - 16
SP - E011003
JO - Circulation: Heart Failure
JF - Circulation: Heart Failure
IS - 12
ER -